Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

β-Carotene Biosynthesis in Probiotic Bacteria.

Miller JK, Harrison MT, D'Andrea A, Endsley AN, Yin F, Kodukula K, Watson DS.

Probiotics Antimicrob Proteins. 2013 Jun;5(2):69-80. doi: 10.1007/s12602-013-9133-3.

PMID:
26782732
2.

β-carotene-producing bacteria residing in the intestine provide vitamin A to mouse tissues in vivo.

Wassef L, Wirawan R, Chikindas M, Breslin PA, Hoffman DJ, Quadro L.

J Nutr. 2014 May;144(5):608-13. doi: 10.3945/jn.113.188391. Epub 2014 Mar 5.

PMID:
24598882
3.

Effect of orally administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs.

Duncker SC, Lorentz A, Schroeder B, Breves G, Bischoff SC.

Vet Immunol Immunopathol. 2006 Jun 15;111(3-4):239-50. Epub 2006 Mar 13.

PMID:
16530848
4.

More than a marine propeller--the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus.

Troge A, Scheppach W, Schroeder BO, Rund SA, Heuner K, Wehkamp J, Stange EF, Oelschlaeger TA.

Int J Med Microbiol. 2012 Dec;302(7-8):304-14. doi: 10.1016/j.ijmm.2012.09.004. Epub 2012 Nov 4.

PMID:
23131416
5.

Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.

Rund SA, Rohde H, Sonnenborn U, Oelschlaeger TA.

Int J Med Microbiol. 2013 Jan;303(1):1-8. doi: 10.1016/j.ijmm.2012.11.006. Epub 2013 Jan 10.

PMID:
23312798
6.

Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.

Schultz M, Watzl S, Oelschlaeger TA, Rath HC, Göttl C, Lehn N, Schölmerich J, Linde HJ.

J Microbiol Methods. 2005 Jun;61(3):389-98.

PMID:
15767015
7.

Decisive role of lipopolysaccharide in activating nitric oxide and cytokine production by the probiotic Escherichia coli strain Nissle 1917.

Zídek Z, Kmonícková E, Kostecká P, Tlaskalová-Hogenová H.

Folia Microbiol (Praha). 2010 Mar;55(2):181-9. doi: 10.1007/s12223-010-0027-4. Epub 2010 May 19.

PMID:
20490762
8.

Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.

Kleta S, Nordhoff M, Tedin K, Wieler LH, Kolenda R, Oswald S, Oelschlaeger TA, Bleiss W, Schierack P.

Infect Immun. 2014 May;82(5):1801-12. doi: 10.1128/IAI.01431-13. Epub 2014 Feb 18.

9.

Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.

Remer KA, Bartrow M, Roeger B, Moll H, Sonnenborn U, Oelschlaeger TA.

Int J Med Microbiol. 2009 Nov;299(7):467-78. doi: 10.1016/j.ijmm.2009.03.003. Epub 2009 May 20.

PMID:
19467927
10.

Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.

Mohsin M, Guenther S, Schierack P, Tedin K, Wieler LH.

Int J Med Microbiol. 2015 Jan;305(1):20-6. doi: 10.1016/j.ijmm.2014.10.003. Epub 2014 Oct 27.

PMID:
25465158
11.

Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction.

Secher T, Kassem S, Benamar M, Bernard I, Boury M, Barreau F, Oswald E, Saoudi A.

Front Immunol. 2017 Sep 14;8:1096. doi: 10.3389/fimmu.2017.01096. eCollection 2017.

12.

Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917.

Trebichavsky I, Splichal I, Rada V, Splichalova A.

Nutr Rev. 2010 Aug;68(8):459-64. doi: 10.1111/j.1753-4887.2010.00305.x. Review.

PMID:
20646223
13.
14.

Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.

Henker J, Laass MW, Blokhin BM, Maydannik VG, Bolbot YK, Elze M, Wolff C, Schreiner A, Schulze J.

Pediatr Infect Dis J. 2008 Jun;27(6):494-9. doi: 10.1097/INF.0b013e318169034c.

PMID:
18469732
15.

The probiotic Escherichia coli Nissle 1917 inhibits propagating colonic contractions in the rat isolated large intestine.

Dalziel JE, Mohan V, Peters J, Anderson RC, Gopal PK, Roy NC.

Food Funct. 2015 Jan;6(1):257-64. doi: 10.1039/c4fo00831f. Epub 2014 Nov 21.

PMID:
25415771
16.

Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization.

Barth S, Duncker S, Hempe J, Breves G, Baljer G, Bauerfeind R.

J Appl Microbiol. 2009 Nov;107(5):1697-710. doi: 10.1111/j.1365-2672.2009.04361.x. Epub 2009 May 20.

17.

Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress.

Konturek PC, Sliwowski Z, Koziel J, Ptak-Belowska A, Burnat G, Brzozowski T, Konturek SJ.

J Physiol Pharmacol. 2009 Dec;60 Suppl 6:41-8.

PMID:
20224150
18.

Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats.

Matuskova Z, Anzenbacherova E, Vecera R, Tlaskalova-Hogenova H, Kolar M, Anzenbacher P.

PLoS One. 2014 Feb 5;9(2):e87150. doi: 10.1371/journal.pone.0087150. eCollection 2014.

19.

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.

Petersen AM, Mirsepasi H, Halkjær SI, Mortensen EM, Nordgaard-Lassen I, Krogfelt KA.

J Crohns Colitis. 2014 Nov;8(11):1498-505. doi: 10.1016/j.crohns.2014.06.001. Epub 2014 Jun 25.

PMID:
24972748
20.

Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins.

Seo EJ, Weibel S, Wehkamp J, Oelschlaeger TA.

Int J Med Microbiol. 2012 Nov;302(6):276-87. doi: 10.1016/j.ijmm.2012.05.002. Epub 2012 Jun 28.

PMID:
22748509

Supplemental Content

Support Center